M S Mcmurtry
Overview
Explore the profile of M S Mcmurtry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
488
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alotaibi G, Alsaleh K, Wu C, Mcmurtry M
Int Angiol
. 2014 Jul;
33(4):301-8.
PMID: 25056161
Aim: Many new oral anticoagulants (NOACs; dabigatran, rivaroxaban, and apixaban) are currently available to treat thromboembolic disease. There are no head-to-head trials comparing these agents. To assess the efficacy and...
2.
Sutendra G, Dromparis P, Kinnaird A, Stenson T, Haromy A, Parker J, et al.
Oncogene
. 2012 May;
32(13):1638-50.
PMID: 22614004
Most solid tumors are characterized by a metabolic shift from glucose oxidation to glycolysis, in part due to actively suppressed mitochondrial function, a state that favors resistance to apoptosis. Suppressed...
3.
Michelakis E, Sutendra G, Dromparis P, Webster L, Haromy A, Niven E, et al.
Sci Transl Med
. 2010 May;
2(31):31ra34.
PMID: 20463368
Solid tumors, including the aggressive primary brain cancer glioblastoma multiforme, develop resistance to cell death, in part as a result of a switch from mitochondrial oxidative phosphorylation to cytoplasmic glycolysis....
4.
Michelakis E, Dyck J, Mcmurtry M, Wang S, Wu X, Moudgil R, et al.
Adv Exp Med Biol
. 2002 Apr;
502:401-18.
PMID: 11950153
Unlabelled: Chronic Hypoxic Pulmonary Hypertension (CH-PHT) is characterized by pulmonary artery (PA) vasoconstriction and cell proliferation/hypertrophy. PA smooth muscle cell (PASMC) contractility and proliferation are controlled by cytosolic Ca++ levels,...